Investigating the Effect of Coenzyme Q10 Supplementation on Cisplatin-Induced Nephrotoxicity in Patients Undergoing Chemotherapy: A Randomized Clinical Trial

Ruhollah Masoumi, Parisa Javadian, Ali Ahmadi, Mehrdad Sepehrni · 2025

Read Investigating the Effect of Coenzyme Q10 Supplementation on Cisplatin-Induced Nephrotoxicity in Patients Undergoing Chemotherapy: A Randomized Clinical Trial by Ruhollah Masoumi, Parisa Javadian, Ali Ahmadi, Mehrdad Sepehrni (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12885188.txt.

Description

Ruhollah Masoumi, Parisa Javadian, Ali Ahmadi, and Mehrdad Sepehrni present a 2025 clinical trial on protecting kidneys during chemotherapy. The cancer drug cisplatin often harms the kidneys, largely through oxidative stress. Coenzyme Q10 is a strong antioxidant, so the team tested it as a shield.

Cancer patients at a teaching hospital in Shahrekord were split at random into two groups. The supplement group took 300 milligrams of the compound daily for eight weeks. Blood tests before and after measured urea, creatinine, and filtration rate. Between the groups, none of these measures differed clearly. Within the treated patients, creatinine rose and filtration fell over the trial, showing the drug's harm was not fully blocked.

Catalog record

CREATORRuhollah Masoumi, Parisa Javadian, Ali Ahmadi, Mehrdad Sepehrni
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE20 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12885188

Browse the full library · About the Tower of Babel